Establishing secure connection…Loading editor…Preparing document…

Business Agreement Pharmaceuticals Inc

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

BUSINESS AGREEMENT — PHARMACEUTICALS INC

This Business Agreement (the Agreement) is entered into as of Effective Date: by and between:

WHEREAS

WHEREAS, Party A is engaged in the research, development, manufacture and distribution of pharmaceutical products and possesses specialized technical knowledge, regulatory approvals, testing protocols and manufacturing capabilities relevant to the subject matter of this Agreement; and

WHEREAS, Party B desires to retain Party A to perform services and/or supply goods related to pharmaceutical development, testing, regulatory support, manufacturing or distribution as set forth in this Agreement, and Party A is willing to perform such services under the terms and conditions contained herein.

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, the parties agree as follows:

SCOPE OF WORK

Party A shall perform the services and deliverables described below. Party A will perform such services with the professional skill and care reasonably expected of experienced pharmaceutical contractors and in compliance with applicable laws, regulations and Good Manufacturing Practices where applicable.

PAYMENT TERMS

In consideration of the services and deliverables, Party B shall pay Party A the fees described below. Unless otherwise stated, fees do not include applicable taxes which shall be borne by the paying party where required by law.

Late payments shall accrue interest and fees as provided below:

TERM AND TERMINATION

This Agreement shall commence on Start Date: and continue until End Date: unless earlier terminated in accordance with this section.

Either party may terminate this Agreement for material breach of its obligations upon written notice that provides the defaulting party a cure period of Notice Period: days. If the breach is not cured within the cure period, the non-breaching party may terminate the Agreement immediately upon written notice.

Upon termination, Party B shall pay Party A for all services performed and non-cancellable commitments incurred through the effective date of termination. Termination shall not relieve either party from liability for obligations accrued prior to termination.

CONFIDENTIALITY

"Confidential Information" means any non-public information disclosed by one party to the other in connection with this Agreement, including but not limited to scientific data, regulatory filings, formulations, manufacturing processes, technical know-how, business plans, pricing and customer information. Each receiving party shall: (a) hold Confidential Information in confidence using at least the same degree of care it uses to protect its own confidential information; (b) not use Confidential Information except to perform its obligations under this Agreement; and (c) not disclose Confidential Information to any third party except to those employees, contractors or advisors who need to know and who are bound by obligations of confidentiality at least as protective as those herein. Confidentiality obligations shall survive termination for a period of five (5) years, except with respect to trade secrets, which shall be protected for as long as they remain trade secrets under applicable law.

INTELLECTUAL PROPERTY AND OWNERSHIP

Unless otherwise expressly agreed in writing, Party A retains all right, title and interest in intellectual property existing prior to or independently of this Agreement. Intellectual property developed solely by Party A in the performance of this Agreement shall remain the sole property of Party A. Intellectual property developed jointly by the parties shall be owned jointly in proportion to each party's inventive contribution, subject to a separate written agreement to govern ownership, prosecution and maintenance. Parties shall execute such documents reasonably required to effectuate the ownership provisions of this section.

INDEMNIFICATION AND LIMITATION OF LIABILITY

Each party shall indemnify, defend and hold harmless the other party from and against any third-party claims arising from its gross negligence, willful misconduct or material breach of this Agreement. Except for indemnification obligations, liability for direct damages shall be limited to the total amounts actually paid by Party B to Party A under this Agreement in the twelve (12) months preceding the event giving rise to the claim. Neither party shall be liable for consequential, incidental, punitive or special damages.

COMPLIANCE AND REGULATORY

Each party shall comply with all applicable laws, regulations and industry standards relevant to the performance of this Agreement, including applicable regulations governing pharmaceuticals, controlled substances, product safety, data privacy and export controls. Party A shall maintain required permits and certifications and shall notify Party B promptly of any regulatory actions or inspections that materially affect performance.

GOVERNING LAW; DISPUTE RESOLUTION

This Agreement shall be governed by and construed in accordance with the laws of Governing Jurisdiction: without regard to conflict of law principles. The parties shall attempt in good faith to resolve disputes by negotiation. If unresolved within 30 days, disputes shall be submitted to arbitration or litigation as agreed by the parties in writing.

ENTIRE AGREEMENT

This Agreement, including any exhibits or schedules attached hereto and executed by the parties, constitutes the entire agreement between the parties concerning its subject matter and supersedes all prior and contemporaneous agreements, understandings and communications, whether written or oral. Any amendment or modification to this Agreement must be in writing and signed by authorized representatives of both parties.

NOTICES

All notices required or permitted under this Agreement shall be in writing and delivered to the addresses set forth above or to such other address as a party may designate in writing. Notices shall be deemed given upon personal delivery, two business days after deposit with a nationally recognized courier, or three business days after deposit in the United States mail, postage prepaid.

MISCELLANEOUS

If any provision of this Agreement is held invalid or unenforceable, the remaining provisions shall remain in full force and effect. No waiver of any breach of this Agreement shall constitute a waiver of any other breach. The parties are independent contractors and nothing in this Agreement creates an employment, partnership or joint venture relationship.

Party A — Printed Name:

By:

Date:

Party B — Printed Name:

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What the Business Agreement Pharmaceuticals Inc covers

The Business Agreement Pharmaceuticals Inc is a formal commercial contract used to set terms between Pharmaceutical Inc and a counterparty for activities such as supply, manufacturing, licensing, research collaboration, or distribution. It defines parties, scope of work, deliverables, pricing, intellectual property ownership, confidentiality, regulatory compliance responsibilities, warranty and indemnity clauses, and termination conditions. The agreement is intended to allocate commercial and regulatory risk, establish performance milestones, and create a clear basis for invoicing and dispute resolution across U.S. jurisdictions.

Why a clear Business Agreement Pharmaceuticals Inc matters

A well-drafted agreement reduces ambiguity about responsibilities, protects intellectual property and confidential data, aligns regulatory obligations, and sets measurable performance and payment terms that mitigate commercial risk for both parties.

Why a clear Business Agreement Pharmaceuticals Inc matters

Who typically completes this agreement

Various internal teams and external counsel collaborate to prepare and sign this agreement depending on role and authority.

  • Legal and compliance teams: Draft and approve contract language, ensure regulatory clauses (FDA, HIPAA) are included.
  • Procurement and supply chain: Negotiate pricing, delivery schedules, and acceptance criteria for manufactured goods.
  • R&D and licensing managers: Define scope for research collaborations, milestone deliverables, and IP assignment.

Final execution requires authorized signatories and, where applicable, witnesses or notarization consistent with governing law.

Core provisions to include in the agreement

These six elements form the backbone of a commercially robust pharmaceutical agreement and should be reviewed by legal and business stakeholders before signature.

Parties

Full legal names and entity types for each contracting party, including state of incorporation and tax identification where required for payments and compliance.

Scope

Detailed description of goods or services, technical specifications, acceptance criteria, and any deliverable schedules tied to milestones or regulatory approvals.

Term

Effective date, initial term, renewal mechanics, and termination rights for convenience, breach, or regulatory events affecting performance.

Payment

Pricing model, payment schedule, invoicing requirements, late payment interest, and responsibilities for taxes or withholding under U.S. law.

IP & Confidentiality

Ownership of inventions, background and foreground IP, license scopes, confidentiality obligations, and permitted disclosures for regulatory filings.

Warranties & Indemnities

Product or service warranties, limitations on liability, indemnity obligations for third-party claims, and any insurance requirements.

Essential data elements to include

Entity Name: Legal corporate name
Address: Physical street address
Tax ID: EIN or TIN
Scope Summary: Concise activity description
Payment Terms: Net days and currency
Signatory Block: Authorized signer details

Step-by-step to prepare and finalize the agreement

Follow a standard sequence from document drafting through execution to reduce rework and ensure regulatory alignment.

  • 01
    Gather materials: Collect prior agreements, regulatory authorizations, and specs.
  • 02
    Draft terms: Populate scope, payment, IP, and compliance clauses.
  • 03
    Internal review: Legal, compliance, and finance review the draft.
  • 04
    Execute: Authorized signatories sign and distribute executed copies.

Configuring a digital workflow for this agreement

Set up your electronic workflow with clear signer roles, authentication, and storage rules to maintain auditability.

Field Configuration
Template name Use unique name for version control
Signer roles Assign roles: Sender | Counterparty | Witness
Authentication method Email link, SMS code, or KBA
Retention location Designate secure cloud or SFTP storage

Typical routing and submission process

A simple four-step flow covers document preparation, distribution, signing, and archiving for electronic execution.

  • Prepare: Upload and place required fields
  • Assign: Designate signer order and roles
  • Sign: Signers authenticate and complete fields
  • Archive: Store executed copy with audit trail

Technical considerations for eSigning and eSubmission

Choose a platform that supports secure authentication, audit trails, and the file formats used in pharmaceutical contracting.

  • File formats: PDF and DOCX support is standard
  • Integrations: Connectors for NetSuite, Salesforce, and Box
  • Security: TLS in transit, AES-256 at rest

Ensure the solution can produce a tamper-evident signed file and export a complete audit trail for regulatory review or audits.

Key dates and notice windows to track

Track contractual milestones and statutory notice periods to avoid penalties and performance disputes.

Effective date:

MM/DD/YYYY when obligations commence

Delivery milestones:

Dates tied to manufacturing or supply schedules

Termination notice:

Number of days required for convenience termination

Renewal window:

Advance notice period to renew or decline

Record retention trigger:

Dates that start retention clocks after termination

Project milestones from negotiation to implementation

Sequence major stages to set expectations for approvals, regulatory filings, and operational handoffs.

01

Drafting

Initial agreement preparation and redline exchange.

02

Negotiation

Commercial and legal teams reconcile terms.

03

Execution

Authorized signatories sign and certify the document.

04

Operational launch

Handover to operations for performance and delivery.

Common preparation mistakes to avoid

  • Ambiguous scope or acceptance criteria that lead to disputes and missed deliveries if not clarified in schedules and exhibits.
  • Omitting explicit IP assignment or license language for jointly developed inventions, leaving ownership unclear after collaboration.
  • Using signatory names without verifying corporate authority or failing to attach a corporate resolution when required for signing.
  • Failing to address regulatory responsibilities, such as FDA submissions or HIPAA protections, which can create compliance gaps.

Legal and commercial risks from incorrect agreements

Breach Damages: Monetary liability exposure
Regulatory Risk: FDA or HIPAA enforcement
Tax Impact: Withholding or reporting issues
Supply Disruption: Delayed product availability
Confidentiality: Loss of trade secret protection
Signature Validity: Execution defects may void clauses

Representative eSignature vendor comparison for contract execution

The table compares basic pricing and availability of selected features that affect high-volume contract workflows; signNow is listed first per vendor ordering rules.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by offer Varies by offer Varies by offer Varies by offer
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Real-world examples of electronic agreement use

These condensed customer examples show how organizations applied digital signing to commercial agreements.

Optica Ventures (COO)

The interface is simple and easy-to-use for our team; more importantly, it is just as easy for our customers.

  • Single-platform signing reduced back-and-forth approvals.
  • As a result, Optica improved turnaround times and reduced manual follow-up while maintaining a clear audit trail for each executed contract.

Xerox (Dir of NetSuite Ops)

airSlate SignNow provides us with the flexibility needed to get the right signatures on the right documents, in the right formats.

  • Integration with NetSuite automated record-keeping.
  • Xerox achieved consistent document formatting, faster routing, and simplified reconciliation between signed agreements and ERP records.

Typical authorized signatories for pharmaceutical contracts

General Counsel

The general counsel typically reviews and approves legal terms and confirms that the selected signatory has authority to bind the corporation under internal governance rules and the corporate charter.

Chief Procurement Officer

The procurement officer negotiates commercial terms and, where delegated authority exists, signs vendor and supplier agreements within predefined financial thresholds.

Practical tips for accurate and efficient completion

Adopt these practices to reduce errors, speed approvals, and ensure the executed agreement is audit-ready.

Standardize templates
Use a master template with approved legal clauses and populated exhibits to reduce negotiation cycles and ensure consistent regulatory language across agreements.
Define signer authority
Maintain a current delegation of authority matrix so signers are verified before execution to avoid unenforceable signatures.
Use conditional fields
Include conditional and required fields for pricing and milestones to prevent incomplete submissions and downstream disputes.
Preserve audit trails
Retain the complete signed PDF and an audit record (timestamps, IP, authentication) to support compliance and dispute resolution.

Frequently asked questions about this agreement

Answers to common execution and compliance questions to help avoid delays and ensure enforceability.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.